Advertisements

Vitcofol INJ

Quick links to important sections

Vitcofol INJ

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Vitcofol INJ

Property Description
Active ingredient Folic Acid, Nicotinamide, Vitamin B12
Form Solution for Injection
Pharmacological class Water-Soluble Vitamins and Antianemic Preparations
Common use Replenishment of essential nutrients
Origin Synthetic compounds

What Type of Medicine is Vitcofol INJ?

Vitcofol INJ is defined as a combination medicine categorized within the pharmacological class of Water-Soluble Vitamins and Antianemic Preparations. It is presented as a sterile Solution for Injection, a parenteral preparation primarily intended for the intramuscular (IM) route or deep subcutaneous injection. This injectable format is a prescription medicine (Rx) and is widely clinically recognized for its efficacy in ensuring the rapid and complete systemic replenishment of essential nutrients, particularly in scenarios where oral absorption is limited or compromised. This key feature of the parenteral preparation differentiates it from lower-dose, non-prescription vitamin supplements.

Composition: Essential B-Complex Active Ingredients

The active ingredients in Vitcofol INJ are three essential synthetic compounds from the B-complex vitamins: Folic Acid (Vitamin B9), Nicotinamide (Vitamin B3), and a form of Vitamin B12, typically Cyanocobalamin or Methylcobalamin. This specific, high-potency combination product is designed to address multiple interconnected deficiencies simultaneously. The combined use of Folic Acid and Vitamin B12 is critical because these two vitamins are mutually dependent for their most important functions, including cellular division. The sterile aqueous vehicle delivers the ingredients directly, supporting their roles as metabolic cofactors in metabolic processes without degradation.

General Purpose: Why is the Combination Vitamin Used?

The general therapeutic purpose of Vitcofol INJ is to correct or prevent severe nutritional deficiency states by ensuring adequate delivery of these three essential vitamins. This targeted replenishment of essential nutrients supports fundamental physiological maintenance and is utilized in patients presenting with deficits related to Vitamin B12 deficiency and Folate deficiency. The injection supports vital body functions, including red blood cell formation, cell multiplication, and maintaining the integrity of the nervous system structure.

Regulatory References

  1. Folate–vitamin B-12 interaction
Advertisements

What side effects are possible with Vitcofol INJ?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety constraints associated with the components of Vitcofol INJ (Folic Acid, Nicotinamide, and Vitamin B12), as categorized in government regulatory documents.


Adverse Reaction Classification

The safety profile documents a distinction between non-serious, generally transient adverse reactions and the potential for rare, serious events. Adverse reactions are grouped by the body system affected (System-Organ Class or SOC), including Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, and Immune System Disorders.

The most significant adverse reactions are typically classified as Rare or Very Rare in official labeling, which includes:

  • Serious Hypersensitivity: Severe allergic reactions, including anaphylaxis, as documented for Vitamin B12 preparations.
  • Cardiovascular Events: Rare occurrences of pulmonary edema or congestive heart failure have been reported following administration in specific contexts.

Population-Specific Safety Constraints

Regulatory documentation includes mandatory restrictions based on pre-existing patient conditions:

  • Leber’s Disease: Use is contraindicated in individuals with Leber’s disease (hereditary optic neuropathy) due to the risk of severe and rapid progression of optic nerve damage.
  • Undiagnosed B12 Deficiency: Administration of Folic Acid is cautioned when a Vitamin B12 deficiency has not been fully diagnosed, as it may correct hematological symptoms while allowing the irreversible progression of neurological damage to continue.

Time- and Exposure-Related Safety Notes

Official labels note that long-term high-dose use of Folic Acid can mask the underlying neurological signs of a concomitant Vitamin B12 deficiency. Furthermore, rapid initial replacement therapy for severe megaloblastic anemia may carry a documented risk of hypokalemia and fluid retention.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Vitcofol INJ (Folic Acid, Nicotinamide, Vitamin B12) indicates that water-soluble vitamins generally possess a wide margin of safety, with excess amounts typically being rapidly excreted. However, documented regulatory profiles list specific manifestations and severe outcomes associated with large doses.

Documented Manifestations and Severe Outcomes

Overdose may present with mild transient diarrhea, itching, transitory exanthema (skin rash), and transient abnormalities of liver function. Regulatory documents also note potential severe outcomes, including pulmonary edema, congestive heart failure (reported early in treatment with high-dose Vitamin B12), and peripheral vascular thrombosis.

Classification Regulatory Status
Antidote Availability No specific antidote is known for the active components.
Treatment Focus Limited to symptomatic and supportive treatment.

When to Seek Immediate Medical Help

Regulators mandate that a regional Poison Control Centre must be contacted immediately for management of a suspected drug overdose. Immediate emergency services (such as 911) must be contacted if the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened. These specific, life-threatening symptoms are stated triggers for urgent medical attention.

Advertisements

Therapeutic Uses of Vitcofol INJ

What Vitcofol INJ Treats: Main Uses and Benefits

Vitcofol INJ is commonly used for the management of conditions stemming from specific nutritional shortfalls, which helps restore systemic balance. The main therapeutic focus is on addressing megaloblastic and other deficiency anemias, as well as neurological symptoms related to Vitamin B12 deficiency.


Addressing Anemia and Blood Cell Support

This product is applied across domains where additional symptomatic support is needed to address deficiencies that affect red blood cell production. It provides key components that assist in stimulating the formation of healthy red blood cells. Its use helps address symptom clusters that may become intense, such as extreme fatigue and general weakness. This support assists patients during episodes of heightened discomfort.


Promoting Healthy Neurological Function

Vitcofol INJ is relevant in contexts where a deficiency, particularly of Vitamin B12, leads to symptoms related to nerve health. It provides critical support for the nervous system, which may assist in managing discomfort and conditions like neuropathy, often presenting as tingling or numbness. This is often used when symptoms intensify and supportive relief is needed.


Quick Fact: Supportive Relief in Situations of Anemia-Related Fatigue (The support assists with maintaining functional stability and may help improve day-to-day comfort.)

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Vitcofol INJ? (Official Regulatory Information)

Eligibility for Vitcofol INJ (Folic Acid, Nicotinamide, Vitamin B12 Injection) is strictly determined by official regulatory documents, focusing on absolute contraindications and population-specific restrictions.

Absolute Contraindications

Use is prohibited in the following populations:

Population/Condition Restriction Basis
Hypersensitivity Known allergy to Cobalt or Vitamin B12 (Cyanocobalamin).
Infants (Neonates) Due to the excipient Benzyl Alcohol (associated with 'Gasping Syndrome').
Early Leber's Disease Risk of severe and swift optic atrophy.

Conditional Use and Age Restrictions

  • Age-Group Eligibility: The injection is contraindicated in infants. Safety and effectiveness in children under 11 years of age are not established by regulatory bodies.
  • Kidney Function: Patients with Impaired Kidney Function must use the product with caution. Prolonged parenteral administration requires monitoring due to the potential for aluminum accumulation.
  • Pregnancy and Lactation: Use is considered conditional. It should be administered during pregnancy or lactation only if clearly needed, as Vitamin B12 is excreted in human milk, and controlled studies are limited.
  • Diagnostic Restriction: The injection must not be used prior to the diagnosis of megaloblastic anemia, as the components can mask the neurological progression of an underlying B12 deficiency.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of the active ingredients in Vitcofol INJ (Folic Acid, Nicotinamide, and Vitamin B12) through effects on serum concentrations, metabolic interference, and pharmacodynamic changes. All interaction information is presented strictly as described in government labeling.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Medicine or Product Official Regulatory Outcome/Restriction
Anticonvulsants (e.g., Phenytoin, Primidone) Folic Acid may antagonize the anticonvulsant action and is documented to potentially increase seizure incidence. These medicines can also interfere with Folic Acid metabolism, reducing its serum concentration.
Methotrexate Folic Acid may decrease the patient’s clinical response to Methotrexate therapy by competing with the antifolate action.
Chloramphenicol May inhibit the hematologic response to the Vitamin B12 component.
Oral Contraceptives Concurrent administration may decrease the serum concentration of the Vitamin B12 component.

Substance and Population Constraints

Heavy, chronic consumption of Alcohol (longer than two weeks) is documented to cause malabsorption of Vitamin B12 and to reduce the absorption and increase the elimination of Folic Acid. Substances such as Colchicine and Para-aminosalicylic acid (PAS) may also produce malabsorption of Vitamin B12.

Administration of the Cyanocobalamin component is a formal contraindication in patients with Leber’s hereditary optic neuropathy due to the documented risk of inducing optic nerve atrophy. Furthermore, a population-specific note exists for patients with impaired renal function, who may be at risk for Aluminum accumulation from the injectable formulation with prolonged parenteral use.

Advertisements

Mechanism of Action

DNA Synthesis and Cellular Maturation Support

The mechanism of action for Vitcofol INJ centers on the supply of B vitamin co-factors, primarily Folic Acid (Vitamin B9) and Cobalamin (Vitamin B12). The active form of B9 provides single-carbon units essential for creating the purine and pyrimidine bases required for DNA production. By fueling this fundamental biosynthetic step, the mechanism enables the necessary replication of cells with high turnover rates, which is crucial for enabling the progression of blood cell precursors to mature erythrocytes and cellular renewal within tissues.


Metabolic Pathway Recirculation and Structural Integrity

The B12 component functions as an essential coenzyme for two key metabolic enzymes, including Methionine Synthase. This interaction is vital for recycling inactive Folate and supporting the continuation of the Methionine and Folate metabolic cycles. This enzymatic role influences the concentration of metabolic intermediates, such as homocysteine. Furthermore, B12 contributes to the synthesis of specific lipids required for the proper formation of the myelin sheath within the peripheral and central nervous systems, supporting nerve conduit integrity.

Advertisements

Dosage and Administration Information

How to use Vitcofol INJ

Vitcofol Injection is a prescription medication designed to address nutritional deficiencies, particularly those related to Vitamin B12, Folic Acid, and Nicotinamide (Vitamin B3). This medicine is for parenteral administration only, meaning it must be delivered through injection and should never be self-administered.


Administration and Dosage

The injection is given by a qualified healthcare professional, such as a doctor or nurse, in a clinical setting like a hospital or clinic. It is typically administered via the intramuscular (IM) route, directly into a large muscle mass (e.g., the gluteus or deltoid muscle), or sometimes via the intravenous (IV) route, injected slowly into a vein or through a dialysis line.

The specific dosage and frequency are determined entirely by the prescribing physician. The regimen is tailored to the individual patient based on their age, the severity of the nutritional deficiency, and their response to treatment. It is critical to adhere strictly to the doctor's instructions and not stop treatment prematurely, even if symptoms begin to improve.


Essential Patient Precautions

  • Medical Disclosure: Before receiving Vitcofol Injection, you must inform your doctor of your complete medical history, including all existing conditions, known allergies to the medication's components, and all other medicines, supplements, or vitamins you are currently taking. This is essential to prevent potential drug interactions or adverse reactions.
  • Monitoring: The healthcare provider may order regular blood tests (such as complete blood count and Vitamin B12 levels) throughout the treatment duration to monitor your progress and ensure the dosage remains appropriate.
  • Storage: The medication should be stored in a clean, dry place, protected from direct light, and kept out of the reach of children and pets.
Advertisements

Recent Clinical Evidence

Vitcofol INJ: Recent Clinical Evidence

Vitcofol Injection is a combination formulation typically containing Cyanocobalamin (Vitamin B12), Folic Acid (Vitamin B9), and Nicotinamide (Vitamin B3). Its established role is in the treatment and prevention of nutritional deficiencies where oral supplementation is insufficient or absorption is impaired.


Evidence for Key Components and Indications

  • Megaloblastic Anemia: The combination of Vitamin B12 and Folic Acid is essential for the synthesis of DNA and the proper maturation of red blood cells. Clinical practice guidelines emphasize parenteral (injectable) Vitamin B12 therapy for conditions like Pernicious Anemia or malabsorption syndromes, as these conditions bypass the body’s natural absorption mechanism in the gut.
  • Neurological Function: Vitamin B12 deficiency is known to affect the nervous system, potentially leading to peripheral neuropathy. Supplementation, especially via injection, is employed to maintain the myelin sheath and support overall nerve health. Studies suggest that early intervention may be critical for addressing neurological complications associated with severe B12 deficiency.
  • Homocysteine Levels and Cardiovascular Risk: Research indicates that Vitamin B12 and Folic Acid work together to lower elevated blood levels of the amino acid homocysteine. While high homocysteine is considered a risk factor for certain cardiovascular conditions and stroke, large-scale intervention trials suggest that lowering it through B-vitamin supplementation does not consistently reduce the risk of major heart attacks.
  • Role in Pregnancy: Folic acid supplementation is strongly supported by evidence to reduce the risk of Neural Tube Defects (NTDs) in a developing fetus when taken before conception and in early pregnancy. Vitamin B12 is also considered crucial for fetal brain and nervous system development, particularly where maternal B12 status is poor.

Key Studies & References

  1. Homocysteine lowering and cardiovascular disease events: meta-analysis of the randomised trials
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Vitcofol INJ (FAQ)

Q: What is Vitcofol INJ?

A: Vitcofol INJ is a combination medication containing Nicotinamide (Vitamin B3), Cyanocobalamin (Vitamin B12), and Folic Acid (Vitamin B9).

It is prescribed as a nutritional supplement to treat or prevent deficiencies of these vitamins. Deficiency of these essential nutrients can lead to various health problems, including certain types of anemia and nerve issues.


Q: How does Vitcofol INJ work in the body?

A: The components of Vitcofol INJ are nutritional supplements essential for various vital body functions:

  • Folic Acid and Cyanocobalamin are crucial for the formation of healthy red blood cells and for proper functioning of the nervous system.
  • Nicotinamide helps the body use fats and carbohydrates for energy and make new proteins. It also supports overall nervous system health.

Together, these vitamins help in improving metabolism, strengthening the immune system, and enhancing general health.


Q: What are the common side effects of Vitcofol INJ?

A: Most side effects related to Vitcofol INJ are temporary and disappear as your body adjusts to the medication. Common side effects may include injection site reactions, such as redness, swelling, and pain. These symptoms do not usually require medical attention. If injection site reactions or any other side effects persist or become bothersome, you should consult your doctor.


Q: Is Vitcofol INJ safe during pregnancy and breastfeeding?

A: * Pregnancy: There is limited information available regarding the use of Vitcofol INJ during pregnancy. You should consult your doctor to discuss the risks and benefits before receiving this injection if you are pregnant or planning to become pregnant.

  • Breastfeeding: Available data suggests that the drug does not pass into breast milk in amounts considered clinically significant, and it is unlikely to harm the infant. This medication is generally considered safe if prescribed by a doctor while breastfeeding.

Q: Can I self-administer the Vitcofol INJ injection?

A: No, you should not self-administer this injection. Vitcofol INJ is an injectable medicine that must be administered under the supervision of a healthcare professional (such as a doctor or nurse) in a medical setting.


Q: What should I do if I miss a dose of Vitcofol INJ?

A: Since Vitcofol INJ is administered by a healthcare professional, missing a dose is uncommon. However, if you miss a scheduled appointment for your injection, contact your doctor or the clinic immediately to arrange for the next dose.

Advertisements

How should Vitcofol INJ be stored and disposed of?

How to Store and Dispose of Vitcofol Injection

Official regulatory information mandates strict environmental controls to maintain the stability of Vitcofol Injection. The product must be stored at Controlled Room Temperature (CRT), typically between 20^circC and 25^circC (68^circF and 77^circF).


Mandatory Conditions

  • Protection: The injection must be protected from light, moisture, and excessive heat; it must not be frozen.
  • Packaging: Keep the medicine in its original container/carton to ensure continuous light protection.
  • Child Safety: Store the product out of the sight and reach of children.
  • Stability: If using a multi-dose vial, any unused portion must be discarded after a defined period (e.g., 30 days) once the vial is punctured.

Disposal

Discard all unused, expired, or leftover medicine according to instructions provided by a healthcare professional or local waste management guidelines for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vitcofol INJ found in:

A-Z Index: